Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.7033
0.00 (0.00%)
At close: Jul 7, 2026, 4:00 PM EDT
0.7200
+0.0167 (2.37%)
After-hours: Jul 7, 2026, 7:58 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $24.72 million as of July 7, 2026. Its market cap has decreased by -63.05% in one year.
Market Cap
24.72M
Enterprise Value
7.92M
1-Year Change
-63.05%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $24.72M, a decrease of -93.06%. That is a compound annual growth rate of -69.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 24.70M | 2.92% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 28.12M |
| BriaCell Therapeutics | 27.87M |
| Plus Therapeutics | 27.39M |
| Polyrizon | 25.83M |
| Barinthus Biotherapeutics | 25.33M |
| NeuroSense Therapeutics | 25.03M |
| Marker Therapeutics | 24.51M |
| Tevogen Bio Holdings | 24.16M |